53,50 €
0,97 % vorgestern
L&S, 3. Oktober, 22:54 Uhr
ISIN
US09073M1045
Symbol
TECH
Berichte

Bio-Techne Corporation Aktie News

Neutral
Seeking Alpha
ein Tag alt
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Neutral
PRNewsWire
9 Tage alt
RNAscope™ technology and the Lunaphore COMET™ enable simultaneous RNA and protein detection on the same tissue section Technologies support spatial multiomic analysis and deeper insights for pathology workflows Research highlights potential role in clinical utility workflows for lymphoid malignancies and B-cell clonality MINNEAPOLIS , Sept. 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDA...
Neutral
PRNewsWire
11 Tage alt
Company advances transition to renewable electricity and sets a pathway to science-based emissions reductions MINNEAPOLIS , Sept. 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate Sustainability Report, underscoring the company's commitment to advancing human health while ...
Neutral
Seeking Alpha
25 Tage alt
Bio-Techne Corporation (NASDAQ:TECH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT Company Participants James Hippel - Executive VP of Finance & CFO Presentation Unknown Analyst All right. Thank you, everyone, for joining today.
Neutral
Seeking Alpha
26 Tage alt
Bio-Techne Corporation (NASDAQ:TECH ) Baird Global Healthcare Conference 2025 September 9, 2025 9:05 AM EDT Company Participants James Hippel - Executive VP of Finance & CFO Conference Call Participants Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Presentation Catherine Ramsey Senior Research Analyst Catherine Schulte.
Neutral
PRNewsWire
26 Tage alt
ST. PAUL, Minn. , Sept. 9, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex Grants, totaling nearly $2 million in support, have been awarded to awardees of the California Institute for Regenerative Medicine (CIRM) Manufacturing Network (INFR5) program.
Neutral
Seeking Alpha
etwa ein Monat alt
Bio-Techne Corporation (NASDAQ:TECH ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 10:15 AM EDT Company Participants Kim Kelderman - CEO, President & Director Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Brandon Couillard MD & Equity Analyst All right. Great. Good morning.
Neutral
PRNewsWire
etwa ein Monat alt
MINNEAPOLIS , Aug. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference September 3, 2025 10:15 AM EDT Baird 2025 Global Healthcare Conference September 9, 2025 9:05 AM EDT Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT A live webc...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen